Lixte Biotechnology (LIXTW) Competitors $0.02 0.00 (-0.47%) As of 04/30/2025 09:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock LIXTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Lixte Biotechnology stock or one of its competitors? The main competitors of Lixte Biotechnology include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Lixte Biotechnology vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Lixte Biotechnology (NASDAQ:LIXTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, community ranking, risk, analyst recommendations, media sentiment, earnings and profitability. Is LIXTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Lixte BiotechnologyN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has better earnings & valuation, LIXTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLixte BiotechnologyN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media refer more to LIXTW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Lixte Biotechnology. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Lixte Biotechnology. Lixte Biotechnology's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.24 indicating that Lixte Biotechnology is being referred to more favorably in the media. Company Overall Sentiment Lixte Biotechnology Very Positive 180 Life Sciences Positive Does the MarketBeat Community favor LIXTW or ATNFW? Lixte Biotechnology and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformLixte BiotechnologyN/AN/A180 Life SciencesN/AN/A SummaryLixte Biotechnology and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Get Lixte Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for LIXTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIXTW vs. The Competition Export to ExcelMetricLixte BiotechnologyBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$123.32M$5.56B$7.83BDividend YieldN/A3.69%5.11%4.22%P/E RatioN/A3.1722.4818.48Price / SalesN/A4,167.71394.56103.59Price / CashN/A13.0238.1834.62Price / BookN/A33.946.774.25Net IncomeN/A-$90.45M$3.22B$248.23M7 Day PerformanceN/A3.87%1.48%0.89%1 Month PerformanceN/A5.27%3.99%3.53%1 Year PerformanceN/A95.02%16.15%5.08% Lixte Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIXTWLixte BiotechnologyN/A$0.02-1.4%N/AN/A$0.00N/A0.004Positive NewsATNFW180 Life SciencesN/A$0.01flatN/A-11.8%$0.00N/A0.007News CoverageLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.02-4.5%N/AN/A$0.00N/A0.002Gap DownAIMDWAinosN/A$0.09+9.6%N/AN/A$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$1.11-14.6%N/A-59.3%$0.00$489.68M0.004Short Interest ↑News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-76.3%$0.00N/A0.0015BFRIWBiofronteraN/A$0.07+30.5%N/AN/A$0.00$37.32M0.0070BTMDWbioteN/A$0.01-2.3%N/A-89.9%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.09+40.0%N/A-86.8%$0.00N/A0.008Gap UpCELUWCelularityN/A$0.04-9.5%N/A+14.0%$0.00$48.20M0.00220Gap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIXTW) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LIXTW Stock Free LIXTW Stock Alerts